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on peripheral vascular and other major vascular outcomes in 20,536
people with peripheral arterial disease and other high-risk conditions
Heart Protection Study Collaborative Group
Objectives. The Heart Protection Study (HPS) provides an opportunity to as-
sess directly the effects of cholesterol-lowering therapy on major vascular
events (defined as myocardial infarction, coronary death, stroke, or revascu-
larisation) in patients with peripheral arterial disease (PAD). In addition, the
effects on peripheral vascular events (ie, noncoronary revascularisation,
aneurysm repairs, major amputations or PAD deaths) can be assessed.
Methods. 6748 UK adults with PAD and 13,788 other high-risk participants
were randomly allocated to receive 40 mg simvastatin daily or matching pla-
cebo, yielding an average LDL cholesterol difference of 1.0 mmol/L (39 mg/
dL) during a mean of 5 years.
Results. For participants with PAD, allocation to simvastatin was associated
with a highly significant 22% (95% CI 15e29) relative reduction in the rate of
first major vascular event following randomisation (895 [26.4%] simvastatin-
allocated vs 1101 [32.7%] placebo-allocated; P < .0001), which was similar to
that seen among the other high-risk participants. The absolute reduction in
first major vascular event was 63 (SE 11) per 1000 patients with PAD and
50 (SE 7) per 1000 without pre-existing PAD. Overall, among all participants,
there was a 16% (5e25) relative reduction in the rate of first peripheral vas-
cular event following randomisation (479 [4.7%] simvastatin vs 561 [5.5%]
placebo), largely irrespective of baseline LDL cholesterol and other factors.
This effect chiefly reflects a 20% (8e31) relative reduction in non-coronary re-
vascularisation procedures (334 [3.3%] vs 415 [4.0%]; P ¼ .002).
Conclusion. HPS demonstrates the benefits of cholesterol-lowering statin ther-
apy in patients with PAD, regardless of their presenting cholesterol levels and
other presenting features. Allocation to 40 mg simvastatin daily reduces the
rate of first major vascular events by about one-quarter, and that of peripheral
vascular events by about one-sixth, with large absolute benefits seen in partic-
ipants with PAD because of their high vascular risk. Consequently, statin ther-
apy should be considered routinely for all patients with PAD.
Comparison of magnetic resonance with computed tomography
angiography for preoperative localization of the Adamkiewicz artery in
thoracoabdominal aortic aneurysm patients
R.J. Nijenhuis, M.J. Jacobs, K. Jaspers, M. Reijnders, Jos M.A. van
Engelshoven, T. Leiner and W.H. Backes
Objective. Preoperative localization of the Adamkiewicz artery and its seg-
mental supplier in advance of thoracic aortic aneurysm (TAA) and thoracoab-
dominal aortic aneurysm (TAAA) repair is proposed to be useful to prevent
postoperative paraplegia. The diagnostic potential of magnetic resonance
angiography (MRA) and computed tomography angiography (CTA) was
evaluated for the preoperative localization of the Adamkiewicz artery in
white TAAA patients.
Methods. Thirty-nine consecutive patients with a TAA(A) scheduled for elec-
tive open surgical aortic repair preoperatively underwent MRA and CTA.
Objective image quality was assessed by measuring the signal-to-noise ratio
and contrast-to-noise ratio of the Adamkiewicz artery and was related to pa-
tient thickness. Two independent observers scored the location of the Adam-
kiewicz artery and the subjective image quality of vessel-background contrast
of the Adamkiewicz artery, image noise, spinal cord tissue enhancement,
epidural venous enhancement, and overall image quality.
Results. Average detection rate for Adamkiewicz artery localization was 71%
(67% to 74%) for CTA and 97% (94% to 100%) for MRA. Interobserver
agreement was 82% for CTA and 94% for MRA. Signal-to-noise ratio was
significantly higher (P < .001) and contrast-to-noise ratio was significantly
(P < .001) lower for CTA than for MRA. Contrast of the Adamkiewicz artery
(P < .001) and overall image quality (P < .004) were judged to be significantly
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1078e5884/000502+ 03 $32.00/0  2007 Published by Elsevier Ltd.better for MRA. Spinal cord tissue enhancement was judged stronger at CTA
(P < .03), with significantly less epidural venous enhancement (P < .001). No
significant difference was found in image noise. Signal-to-noise and contrast-
to-noise decreased significantly (P < .001) with increasing patient thickness
for CTA but not for MRA.
Conclusions. Localization of the Adamkiewicz artery in white TAAA patients
is possible with both CTA and MRA. Compared with CTA, MRA is more fa-
vorable because of the higher Adamkiewicz artery detection rate, the higher
contrast-to-noise ratio, and its independence of patient thickness.
Early complications and long-term outcome after open surgical
treatment of popliteal artery aneurysms: Is exclusion with saphenous
vein bypass still the gold standard?
Y. Huang, P. Gloviczki, A.A. Noel, T.M. Sullivan, M. Kalra, R.E. Gullerud,
T.L. Hoskin and T.C. Bower
Background. Popliteal artery aneurysms (PAAs) are rare, but thromboembolic
complications may result in limb loss. To define complications and outcomes
after open surgical repairs, we reviewed our experience.
Methods. Clinical data of patients with PAA seen between 1985 and 2004
at Mayo Clinic, Rochester, Minnesota, were reviewed and outcomes in
289 patients with open revascularization were analyzed. Kaplan-Meier
method with log-rank tests, c2, and Wilcoxon rank sum tests were used
for analysis.
Results. A total of 358 PAAs were treated in 289 patients, consisting of 281
(97%) men and eight (3%) women. There were 133 (46%) unilateral and 156
(54%) bilateral PAAs with a mean diameter of 2.9 cm (range, 1.5 to 9 cm). Ab-
dominal aortic aneurysm (AAA) was more frequent with bilateral than uni-
lateral PAAs (65% [101/156] vs 42% [56/133] P ¼ .001). There were 144 (40%)
asymptomatic limbs (group 1), 140 (39%) had chronic symptoms (group 2),
and 74 (21%) had acute ischemia (group 3). Great saphenous vein (GSV)
was used in 242 limbs (68%), polytetrafluoroethylene (PTFE) in 94 (26%),
and other types of graft in 22 (6%). Early mortality was 1% (3/358), all in
group 3 (4% [3/74]). Six of seven patients with perioperative myocardial in-
farctions belonged to group 3 (8%). The 30-day graft thrombosis rate was 4%,
with 1% in group 1 (1/144), 4% in group 2 (5/140), and 9% in group 3 (7/74).
All six early amputations (8%) were in group 3, five with failed bypass
(4 PTFE, 1 GSV). Mean follow-up was 4.2 years (range, 1 month to 20.7 years).
The 5-year primary and secondary patency rates were 76% and 87%, respec-
tively, higher with GSVs (85% and 94%) than PTFE (50% and 63%, P < .05).
Seven recurrent PAAs (2%) required reintervention. The 5-year freedom
from reintervention was 100% after endoaneurysmorrhaphy vs 97% after
ligations (P ¼ .03). Five-year limb salvage rate was 97% (85% in group 3).
There was no limb loss in group 1 and none in group 2 with GSV. In group
3, preoperative thrombolysis reduced the amputation rate in class II patients
with marginally threatened limbs (96% vs 69%, P ¼ .02).
Conclusion. Acute presentation of PAA continues to carry high mortality and
cardiac morbidity; although preoperative thrombolysis appears to improve
results, the 8% early and 15% late amputation rates remain ominous. Early
elective repair is recommended because these patients had no surgical mor-
tality, a low rate of complications, and asymptomatic patients had no limb
loss at 5 years. GSV and endoaneurysmorrhaphy continues to be the gold
standard for open repair of PAA.
Determining the quantity and character of carotid artery embolic debris
by electron microscopy and energy dispersive spectroscopy
B.G. DeRubertis, R.A. Chaer, R. Gordon, H. Bell, R.L. Hynecek, F.M. Pieracci,
J. Karwowski, K.C. Kent and P.L. Faries
Objectives. Carotid artery angioplasty and stenting (CAS) is now routinely
performed with embolic protection devices, yet little is known about the com-
positional characteristics of the captured embolic debris and whether the typeMarch 2007  502/504
503Abstractsor quantity of debris correlates with patient, lesion, or operator characteris-
tics. This study examined the embolic debris generated during CAS using
electron microscopy and energy dispersive spectroscopy (EDS) for symptom-
atic and asymptomatic patients.
Methods. Between 2003 and 2005, CAS for carotid stenosis was performed in
175 patients. Cerebral protection devices were used in all but three cases.
Sixty-four consecutive unselected microporous filters from procedures per-
formed by a single vascular surgeon were obtained for analysis. Captured
particulate debris within the protection devices was quantified (number
and mean size of particles) by light microscopy for all filters. Twenty protec-
tion devices (9 symptomatic, 11 asymptomatic patients) were processed for
electron microscopy and EDS to assess morphology, cellular composition,
and calcium content of debris.
Results. Captured particulate matter was present in 49 filters (77%) and in-
cluded particles measuring 200 to 500 mm in 72%, 500 to 1000 mm in 53%, and
>1000 mm in 33%. The mean number of captured particles was 6.9, and mean
size was 248 150 mm. Univariate analysis revealed that sequential patient co-
hort and filter type were correlated with the number (but not size) of captured
particles. Thenumberofparticles significantlydecreasedafter thefirst cohort of
20patients (11.5 particles) comparedwith the second (5.0 particles,P¼.023) and
third (5.2 particles, P ¼ .029) cohorts. The type of captured debris ranged from
sheets of damaged red blood cells without other components to clumps of re-
cently activated platelets with early fibrin crosslinking to plaque debris coated
with well-organized coalescing areas of platelet thrombus. Platelet activation
wasmore common in symptomatic patients (78%) than asymptomatic patients
(27%; P < .05). Despite the presence of calcified lesions in six patients whose
filters were analyzed by EDS,<1% of energy emission on EDS of scanned par-
ticulate debris fellwithin the emission rangeof calcium, indicating thepresence
of minimal calcium in the embolic particles.
Conclusions. Particulate embolic debris is released in most patients during
CAS and can measure >1000 mm in one third of patients. The number of par-
ticles may decrease with increasing operator experience with CAS. Debris
captured during CAS with embolic protection exhibits a range of cellular
and acellular components on electron microscopy, with a higher prevalence
of platelet activation evident in symptomatic patients.
Clinical Relevance. This research represents the examination of the debris
products generated during carotid stenting and captured in embolic protec-
tion filters. The size, amount, and composition of the debris has been exam-
ined and correlated with preoperative patient, lesion, and operator
characteristics. Although release of debris during these procedures is likely
a ubiquitous occurrence, the nature and amount of debris may vary substan-
tially with different patient subgroups. A greater understanding of the debris
generated during angioplasty and stenting, as well as the characteristics of
those patients who generate the most debris, may lead to improved treatment
methods and outcomes.
Plasma creatine kinase indicates major amputation or limb preservation
in acute lower limb ischemia
I.S. Currie, S.J. Wakelin, A.J. Lee and R.T. Chalmers
Objective. Acutely ischemic limbs are often of uncertain viability. To assist
operative management, this study determined prospectively which indica-
tors on admission were the best predictors of major amputation and, con-
versely, limb preservation.
Methods. Data were collected on admission. Presenting complaint, history,
clinical assessment, and blood test results, including creatine kinase (CK),
were recorded. Surgical procedures were noteddin particular, the presence
or absence of major amputation by death or discharge. The setting was a ter-
tiary vascular referral center in a university teaching hospital. Subjects
included all patients referred as emergency cases to the vascular unit over
an 18-month period who were admitted for inpatient management with acute
lower limb ischemia. The main outcome measure was major amputation.
Results. A total of 97 patients with acute ischemia were studied prospectively
(51 men and 46 women). Twenty-one patients (21.6%) underwent major am-
putation. Previous vascular surgery (P ¼ .012), mottling (P ¼ .001), sensory
loss (P ¼ .003), motor loss (P ¼ .001), muscle tenderness (P < .001), absent
ankle Doppler signals (P ¼ .008), neutrophilia (P ¼ .011), and increased CK
(P < .001) were significantly associated with major amputation. If CK was
normal, the risk of major amputation was 4.6% (95% confidence interval,
0.0%-9.7%). If CK was increased, the risk was 56.2% (95% CI, 39.1%-73.4%).Conclusions. Specific clinical findings were significantly associated with ma-
jor amputation. Of these, only CK had a positive predictive value greater than
50%. Plasma CK can assist operative management of acute lower limb
ischemia by quantifying prospectively the risk of major amputation or
limb preservation on admission.
Superficial femoral artery percutaneous intervention is an effective
strategy to optimize inflow for distal origin bypass grafts
A. Schanzer, C.D. Owens, M.S. Conte and M. Belkin
Background. Iliac angioplasty in preparation for an infrainguinal bypass graft
has been shown to be an effective strategy. We undertook this study to deter-
mine if superficial femoral artery (SFA) angioplasty offers durable inflow for
distal origin grafts originating from the SFA or popliteal artery.
Methods. All distal origin grafts performed at a single institution between
1988 and 2006, 30 days of an ipsilateral SFA percutaneous intervention,
were reviewed retrospectively. Patients were identified from a computerized
vascular registry, and data were obtained by review of patient charts, angio-
grams, and duplex studies.
Results. We identified 23 autogenous distal origin grafts procedures per-
formed distal to an SFA intervention, of which 22 were performed for critical
limb ischemia (96%). The SFA lesions intervened on (20 angioplasty alone, 3
angioplasty with stenting) included 11 TransAtlantic Inter-Society Consensus
(TASC) A (48%), seven TASC B (30%), five TASC C (22%), and no TASC D
(0%). Of the bypasses, five originated from the distal SFA, five originated
from the above knee popliteal artery, and 13 originated from the below
knee popliteal artery. A significant majority of the patients (87%) were dia-
betic. No deaths, amputations, or early graft failures occurred during the
perioperative period. The mean duration of follow-up was 40.8 months. By
life-table analysis, the primary patency rate was 58% at 5 years. The primary
assisted patency rate was 69% at 5 years. Of the seven interventions required
to maintain patency, only one targeted the SFA. None of the graft failures
could be specifically attributed to disease progression of the SFA. The
5-year limb salvage rate was 70% and the survival rate was 65%.
Conclusions. Percutaneous SFA intervention in preparation for a distal origin
graft is a useful and effective strategy in select patients. The durability ap-
pears comparable with distal origin grafts performed in the absence of an
SFA intervention. This strategy provides a good option in the setting of
both atherosclerotic SFA disease and limited autogenous conduit.
Depression is associated with worse patency and recurrent leg
symptoms after lower extremity revascularization
G.S. Cherr, J. Wang, P.M. Zimmerman and H.H. Dosluoglu
Objectives. Depression is associated with worse outcomes after coronary ar-
tery bypass surgery, but its association with the results after revascularization
for symptomatic peripheral arterial disease (PAD) is unknown. This study as-
sessed the association between depression and patency, recurrent symptoms,
and limb salvage after revascularization for symptomatic PAD.
Methods. Electronic medical records were retrospectively reviewed for all pa-
tients with symptomatic PAD who underwent intervention (open, endovas-
cular, or combined) between January 2000 and October 2004. All patients
were previously screened for depression, and treatment was initiated as indi-
cated by the primary care physician or psychiatrist. Demographic data and
outcomes were recorded using published guidelines. Outcomes of interest
included primary patency of the revascularization (bypass graft or angio-
plasty/stented artery), assisted primary patency, secondary patency, recur-
rent symptomatic ipsilateral PAD, and major amputation. Follow-up was
available for all patients (mean, 23.4  14.1 months).
Results. Board-certified vascular surgeons performed all interventions. At the
time of intervention, 78 (36.1%) of 216 patients had been diagnosed with de-
pression. Compared with those without depression, depressed patients were
younger (64.4 vs 69.1 years; P ¼ .001), currently using tobacco (74.4% vs
51.4%; P ¼ .001), and less likely to have hypertension (79.5% vs 89.9%; P ¼
.03). No other significant differences were noted for cardiovascular risk
factors or prevalent comorbidities. During follow-up, 50 patients (23.1%)
had failing or failed revascularizations, and 24 (11%) had amputations. Those
with depression at the time of the PAD intervention, compared at 24 months
with patients without depression, had significantly worse primary patencyEur J Vasc Endovasc Surg Vol 33, April 2007
504 Abstracts(58.2% vs 79.8%; P ¼ .02), primary assisted patency (59.5% vs 81.5%; P ¼ .01),
and secondary patency (60.2% vs 82.2%; P ¼ .007). They also had a signifi-
cantly increased risk of recurrent symptomatic PAD (33.7% vs 20.8%;
P ¼ .03) but not major amputation (13.8% vs 10.4%; P ¼ .73). By multivariate
analysis, patients with depression were at significantly increased risk for re-
current symptomatic PAD (hazard ratio [HR], 1.77; 95% confidence interval
[CI], 1.03 to 3.02; P ¼ .04) and failure of revascularization (HR, 2.18; 95%
CI, 1.22 to 3.88; P < .01), but not major amputation.
Conclusions. Depression is common among patients undergoing intervention
for symptomatic PAD. After intervention, patients with depression have
worse outcomes for the affected leg. Prospective analysis is required to con-
firm these results.
Endovenous laser treatment of the short saphenous vein: Efficacy and
complications
K.D. Gibson, B.L. Ferris, N. Polissar, B. Neradilek and D. Pepper
Objective. The study was conducted to assess the efficacy and rate of compli-
cations of endovenous laser treatment (EVLT) of the short saphenous vein
(SSV).Eur J Vasc Endovasc Surg Vol 33, April 2007Methods. During a 17-month period, 210 (187 patients) with SSV incompe-
tence documented by duplex ultrasound studies were treated with EVLT us-
ing a 980-nm diode laser. Duplex ultrasound examinations were performed
on the day of the procedure, within the first week, and 2 to 11 months after
the procedure (mean follow-up, 4 months). Clinical examinations were
performed at 2 weeks and 6 weeks. Patients were assessed for deep venous
thrombosis (DVT), nerve injury, and resolution of symptoms.
Results. All procedures were technically successful, and in the 126 patients
(60%) who completed final follow-up scanning, 96% of SSVs remained closed.
Three patients (1.6%) had numbness at the lateral malleolus at the 6-week
follow-up. DVT, defined as a tail of thrombus protruding into the popliteal
vein, was not detected in any limbs at the initial duplex study, but was noted
in 12 limbs (5.7%) at the 1-week follow-up examination. Nine patients were
treated with 3 days to 3 months of fractionated heparin and Coumadin
(Bristol-Myers Squibb, Princeton, NJ), and there were no DVT extensions or
pulmonary emboli. The anatomic configuration of the saphenopopliteal
junction was the only factor predictive of DVT.
Conclusions. Intermediate-term results of EVLT of the SSV demonstrate that
the technique is effective at eliminating SSV reflux and affording symptom-
atic relief. The incidence of nerve injury is low, but the incidence of DVT is
higher than reported for the great saphenous vein. Anatomic features of
the SSV may predict patient risk for DVT.
